BUSINESS

Japan's Nikkei 225 closed above 70,000 for the first time in about three months, as AI demand and market momentum lifted semiconductor, banking, automotive and healthcare stocks.

Major brokers have issued buy ratings on 10 ASX 200 companies after a market sell-off, highlighting potential upside while warning that price targets and risks can change quickly.

New York's wealthy are increasing their interest in Florida after Zohran Mamdani's mayoral victory, although experts say the migration predates his election and is not one-way.

SpaceX shares have climbed above $170 after a strong post-listing run, but analysts disagree sharply over whether AI, Starlink and Starship justify the company's enormous valuation.

Maas Group Holdings shares fell 5.75% to A$6.39 as investors awaited settlement of the company's proposed A$1.7 billion construction-materials sale to Heidelberg Materials Australia.

Australia's official inflation data do not rank 10 supermarket products. The ABS recorded electricity up 22.4%, while food rose 3.3% and automotive fuel fell.

Australia's S&P/ASX 200 slipped 0.05 per cent as declines in banks and major iron ore miners offset gains in gold stocks, while weaker consumer sentiment weighed on rate-sensitive shares.

PYC Therapeutics shares fell nearly 8% amid heightened volatility, with investors focused on upcoming safety and efficacy data for its experimental treatment for inherited kidney disease.

Domino's Pizza Enterprises shares climbed about 4% to A$21.18, moving above the average analyst target despite no new company announcement or change to its forecasts.

Elon Musk's estimated fortune has risen above $1 trillion after SpaceX and Tesla shares rallied, though his wealth remains highly vulnerable to market volatility.

Spyre Therapeutics shares fell 13% after the biotech priced a $350 million stock sale at an 8.3% discount, funding trials while diluting existing shareholders.

Option Care Health shares jumped 33% after McKesson and Clayton Dubilier & Rice agreed to take the infusion-therapy company private for about $5.8 billion, including debt.

Japan's Nikkei 225 climbed above 70,000 to a three-month high, supported by Wall Street gains, lower oil prices and expectations of a less aggressive Federal Reserve.

PYC Therapeutics shares gained 5.1% as investors looked ahead to clinical data for PYC-003, an experimental RNA treatment for inherited polycystic kidney disease.

Australian SMEs in defence, creative industries, music and regional tourism can apply for government grants of up to $800,000, with several programmes closing in October.

Sydney's crowded removalist market offers residents many choices, but comparing independent reviews, insurance, accreditation and detailed quotes can help reduce moving risks.

EQ Resources shares fell 11% despite record quarterly revenue, production and cash, as investors took profits after a rally of more than 500% this year.

Australian shares extended their recovery, with the S&P/ASX 200 rising 0.57% as property stocks and miners advanced despite sharply weaker consumer confidence following the RBA's rate hike.

Inter&Co shares rose 26% to $6.89 on heavy volume, with no new company announcement explaining the move. The stock remains below analysts' average price target.

XP shares climbed 33% to a 52-week high after Flávio Bolsonaro exceeded polling expectations in Brazil's first presidential round, intensifying investor optimism but leaving markets exposed to runoff uncertainty.

Chipotle shares fell nearly 4% after JPMorgan lowered its price target and an unconfirmed deal rumour surfaced, with investors focused on weak traffic, margins and the upcoming earnings report.

Coca-Cola Consolidated shares rose 0.4% to $192.81 as investors assessed strong first-half volume and sales growth, debt reduction and pressure from higher aluminium costs before third-quarter results.

Tesla shares rose for a second consecutive session after quarterly vehicle deliveries exceeded analyst forecasts, while investors turned their focus to earnings, margins, energy storage and autonomous-driving plans.

Nvidia shares climbed as the company said OpenAI's faster GPT-6 Astra Ultrafast service runs on Blackwell processors, while investors weighed inference demand against regulatory and competitive risks.

GameStop shares have risen about 30% in a month as CEO Ryan Cohen and other insiders buy stock, while stronger profits and options activity fuel investor optimism.

PTC shares jumped more than 35% after Schneider Electric agreed to acquire the industrial software maker for $22.6 billion, expanding its industrial AI business.

Britain's FTSE 100 rose 0.4% after its worst week since April, supported by mining shares and weaker-than-expected US jobs data that reduced expectations of a Federal Reserve rate rise.

Vaxcyte shares surged after its experimental VAX-31 pneumococcal vaccine met the main goals of a late-stage trial, though regulatory approval and commercial manufacturing remain years away.

Novig reported sharp increases in trading volume, new depositors and app downloads after Sydney Sweeney's ad launched, but the figures do not separate its impact from the NFL season.